National Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control, Bilthoven, The Netherlands.
Epidemiol Infect. 2013 Jun;141(6):1310-7. doi: 10.1017/S0950268812001884. Epub 2012 Sep 11.
A population-based anti-hepatitis C virus (HCV) prevalence is important for surveillance purposes and it provides insight into the burden of disease. The outcomes of recent studies in the general Dutch population as well as recent HCV data from specific risk groups including migrants, men who have sex with men (MSM) and injecting drug users (IDUs), were implemented in a modified version of the Workbook Method (a spreadsheet originally designed for HIV estimations), to estimate Dutch HCV seroprevalence. The estimated national seroprevalence of HCV was 0·22% (min 0·07%, max 0·37%), corresponding to 28 100 (min n = 9600, max n = 48 000) HCV-infected individuals in The Netherlands. Of these, first-generation migrants from HCV-endemic countries (HCV prevalence ≥2%) accounted for the largest HCV-infected group, followed by IDUs and HIV-positive MSM.
基于人群的抗丙型肝炎病毒 (HCV) 流行率对于监测目的很重要,它可以深入了解疾病负担。最近在荷兰普通人群中进行的研究结果以及来自特定风险群体(包括移民、男男性行为者 (MSM) 和注射吸毒者 (IDU))的最近 HCV 数据,被纳入了改良版的工作簿方法(最初用于 HIV 估计的电子表格),以估计荷兰 HCV 血清流行率。估计的全国 HCV 血清流行率为 0.22%(最小值 0.07%,最大值 0.37%),相当于荷兰有 28100 名(最小值 n=9600,最大值 n=48000)HCV 感染者。其中,来自 HCV 流行国家(HCV 流行率≥2%)的第一代移民占 HCV 感染者最大的群体,其次是 IDU 和 HIV 阳性 MSM。